GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Trimurthi Ltd (BOM:536565) » Definitions » Valuation Rank

Trimurthi (BOM:536565) Valuation Rank


View and export this data going back to 2009. Start your Free Trial

What is Trimurthi Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Trimurthi Valuation Rank Related Terms

Thank you for viewing the detailed overview of Trimurthi's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Trimurthi (BOM:536565) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Trimurthi Ltd (BOM:536565) » Definitions » Valuation Rank
Comparable Companies
BOM:540695 BOM:530697 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO SHSE:600739 TSE:9987 SHSE:600056 SZSE:000028 XKRX:008930 TSE:8129
Traded in Other Exchanges
N/A
Address
Chirag Ali Lane, 5-8-354/1106, office No. 1106, Ratna Block, Raghav Ratna towers, Abids, Hyderabad, TG, IND, 500001
Website
https://www.trimurthidrugs.com
Trimurthi Ltd is an India based pharmaceutical supplier. It operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, Foods, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas.